427 results on '"Dono, K."'
Search Results
52. Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression.
- Author
-
Ota, H., Nagano, H., Sakon, M., Eguchi, H., Kondo, M., Yamamoto, T., Nakamura, M., Damdinsuren, B., Wada, H., Marubashi, S., Miyamoto, A., Dono, K., Umeshita, K., Nakamori, S., Wakasa, K., and Monden, M.
- Subjects
LIVER cancer ,PORTAL vein ,THROMBOSIS ,BLOOD coagulation ,CANCER treatment ,INTERFERONS ,FLUOROURACIL ,DRUG therapy ,PROTEINS ,DISEASE progression ,SURVIVAL ,RESEARCH ,LIVER tumors ,TIME ,RESEARCH methodology ,ANTINEOPLASTIC agents ,CELL receptors ,HEPATITIS viruses ,HEPATITIS C ,PROGNOSIS ,MEDICAL cooperation ,EVALUATION research ,TREATMENT effectiveness ,COMPARATIVE studies ,MEMBRANE proteins ,HEPATOCELLULAR carcinoma ,DISEASE remission ,SUBCUTANEOUS injections - Abstract
We previously reported the beneficial effects of combination therapy of interferon (IFN)-alpha/5-fluorouracil (FU) for advanced hepatocellular carcinoma (HCC) with tumour thrombi in the major portal branches. This report describes the results of longer follow-up and includes more than double the number of patients relative to the original report, and evaluates the role of IFN-alpha/type 2 interferon receptor (IFNAR2) expression on the response to the combination therapy. The study subjects were 55 patients with advanced HCC and tumour thrombi in the major branches of the portal vein (Vp3 or 4). They were treated with at least two courses of IFN-alpha/5-FU without major complication. In the 55 patients, 24 (43.6%) showed objective response (eight (14.5%) showed complete response, 16 (29.1%) partial response), four (7.3%) showed no response, and 27 (49.1%) showed progressive disease. Immunohistochemically, IFNAR2 expression was detected in nine out of 13 (69.2%) patients. There was significant difference in the time-to-progression survival (P = 0.0002) and the overall survival (P < 0.0001) between IFNAR2-positive and -negative cases. There was a significant correlation between IFNAR2 expression and response to IFN-alpha/5-FU combination therapy in univariate analysis (P = 0.0070). IFN-alpha/5-FU combination therapy is a promising modality for advanced HCC with tumour thrombi in the major portal branches and could significantly depend on IFNAR2 expression. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
53. Interstitial pneumonia induced by combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma.
- Author
-
Yamamoto S, Tomita Y, Hoshida Y, Iizuka N, Marubashi S, Miyamoto A, Nagano H, Dono K, Umeshita K, Nakamori S, Sakon M, Aozasa K, and Monden M
- Abstract
Previously we reported combined chemo-immunotherapy, using interferon (IFN)-alpha and 5-fluorouracil (5-FU) for patients with advanced hepatocellular carcinoma (HCC), and this regimen improved the prognosis. Recently, we experienced an HCC patient who died of severe interstitial pneumonia during the combined IFN-alpha and 5-FU therapy. This is the first report of the occurrence of interstitial pneumonia during combined IFN-alpha and 5-FU treatment. A 60-year-old-man was admitted to Osaka University Hospital to receive systemic chemo-immunotherapy for recurrent HCC. In the second week of the chemo-immunotherapy, he showed a decreased level of consciousness, and respiratory insufficiency. Emergency roentgenogram revealed diffuse infiltration in both lungs. Respiratory dysfunction due to interstitial pneumonia was suspected, and steroid pulse therapy was started. However, the patient showed respiratory failure, and he died 32 days after the start of the therapy. Autopsy findings showed atelectasis in the bilateral lungs, which showed elastic hard solidity and a dark red color; esophageal varices were also shown, and there was cirrhosis with a large tumor in the liver. Microscopically, the alveolar wall showed marked fibrous thickness and moderate inflammatory change, which is consistent with acute interstitial pneumonia, and the acute pulmonary change was suspected to have been the cause of death. The association of IFN with the development of interstitial pneumonia has been reported. However, the prognosis of IFN-induced interstitial pneumonia has mostly been favorable when the medication was discontinued. It has been postulated that interstitial pneumonia induced by the combination of IFN and 5-FU may be therapy-resistant. The combination of IFN-alpha and 5-FU is a useful therapy for patients with advanced HCC, such as that with portal vein invasion or multiple metastatic foci. Thus, interstitial pneumonia in these patients should be carefully managed. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
54. Evaluation of regional liver damage by magnetic resonance imaging with superparamagnetic iron oxide in rat liver.
- Author
-
Murakami, Takamichi, Kim, Tonsok, Takamura, Manabu, Shimizu, Junzo, Hori, Masatoshi, Dono, Keizo, Takachi, Ko, Kato, Naoki, Miyazawa, Tomoaki, Sakon, Masato, Monden, Morito, Nakamura, Hironobu, Murakami, T, Kim, T, Takamura, M, Shimizu, J, Hori, M, Dono, K, Takachi, K, and Kato, N
- Abstract
The purpose of this study was to investigate whether regional liver damage could be detected by means of enhanced MR imaging with a superparamagnetic iron oxide (SH U 555A) in an ischemia-reperfusion model of rat liver. Ischemic liver damage was induced in the right lobe by vascular clamping for 0 (sham), 30 (I-30), 60 (I-60), and 90 minutes (I-90). There was no significant difference in relative enhancement (RE) between the ischemic and nonischemic lobes in the sham, I-30 and I-60 groups, while RE of the ischemic lobe was significantly lower than that of its nonischemic counterpart in the I-90 group as seen on SH U 555A enhanced proton density spin echo images (P < 0.05). Histological examination revealed that iron deposits were significantly smaller in the ischemic than the nonischemic lobe in the I-90 group (P < 0.05), although there was no significant difference in the number of Kupffer cells. Our results indicate that severe regional liver damage can be evaluated by MR imaging with SH U 555A. [ABSTRACT FROM AUTHOR]
- Published
- 2001
- Full Text
- View/download PDF
55. Presence of active hepatitis associated with liver cirrhosis is a risk factor for mortality caused by posthepatectomy liver failure.
- Author
-
Eguchi, Hidetoshi, Umeshita, Koji, Sakon, Masato, Nagano, Hiroaki, Ito, Yasuhiro, Kishimoto, Shin-ichi, Dono, Keizo, Nakamori, Shoji, Takeda, Tsutomu, Gotoh, Mitsukazu, Wakasa, Kenichi, Matsuura, Nariaki, Monden, Morito, Eguchi, H, Umeshita, K, Sakon, M, Nagano, H, Ito, Y, Kishimoto, S I, and Dono, K
- Abstract
The histologic activity of associated hepatitis was examined in 285 patients who underwent hepatectomy for hepatocellular carcinoma (HCC), to determine if the histologic activity is an independent risk factor for postoperative mortality due to liver failure. The proportion of patients with liver cirrhosis who died due to liver failure (6/180, 3.3%) was not different from that of patients with chronic hepatitis (2/68, 2.9%). However, mortality was higher in patients with liver cirrhosis and active hepatitis (4/46, 8.7%) than in those with cirrhosis and inactive hepatitis (2/134, 1.5%, P < 0.05). Such difference was not observed in the chronic hepatitis group. Multivariate analysis showed that clearance of indocyanine green at 15 min (ICGR15) and activity of hepatitis were two independent risk factors for postoperative mortality due to liver failure. In conclusion, histologic activity of associated hepatitis should be taken into account in hepatic resection of HCC in cirrhotic liver, in addition to the functional reserve of the liver. [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF
56. Development of a multiple-marker RT-PCR assay for detection of micrometastases of hepatocellular carcinoma.
- Author
-
Miyamoto, Atsushi, Fujiwara, Yoshiyuki, Sakon, Masato, Nagano, Hiroaki, Sugita, Yurika, Kondo, Motoi, Eguchi, Hidetoshi, Dono, Keizo, Umeshita, Koji, Nakamori, Shoji, Monden, Morito, Miyamoto, A, Fujiwara, Y, Sakon, M, Nagano, H, Sugita, Y, Kondo, M, Eguchi, H, Dono, K, and Umeshita, K
- Abstract
We investigated the expression of several candidate gene markers: MAGE-1, MAGE-3, cytokeratin-20 (CK-20), and alpha-fetoprotein (AFP) in tumor tissue and blood specimens from patients with hepatocellular carcinoma to develop a multiple marker reverse transcriptase-polymerase chain reaction (RT-PCR) assay for detection of micrometastasis in circulation. In 24 tumor specimens, the positivity for MAGE-1, MAGE-3, AFP, and CK-20 genes was 71, 67, 88, and 79% respectively, and all specimens expressed at least one marker. Although AFP and CK-20 transcripts were also detected in corresponding noncancerous liver specimens, none of the 22 corresponding normal specimens or seven normal livers were positive for MAGE-1 or MAGE-3 transcripts. In addition, MAGE-1 and MAGE-3 gene transcripts were not detected in any peripheral blood specimens from 31 normal healthy volunteers. MAGE-1, MAGE-3, and AFP transcripts were detected in 9 (12.7%), 3 (4.8%), and 10 (15.9%) of 71 blood specimens from 11 hepatocellular carcinoma patients, respectively, while 19 specimens (26.8%) were positive for at least one marker. Our results indicate that a multimarker RT-PCR assay with cancer-specific markers such as MAGE-1 and MAGE-3 in combination with a liver-specific AFP marker may be a promising diagnostic tool for monitoring hepatocellular carcinoma patients with better sensitivity and specificity. [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF
57. Evaluation of regional liver function by gadolinium-EOB-DTPA-enhanced MR imaging.
- Author
-
Shimizu, Junzo, Dono, Keizo, Gotoh, Mitsukazu, Hasuike, Yasunori, Kim, Tonsok, Murakami, Takamichi, Sakon, Masato, Umeshita, Koji, Nagano, Hiroaki, Nakamori, Shoji, Kato, Naoki, Miyazawa, Tomoaki, Nakamura, Hironobu, Monden, Morito, Shimizu, J, Dono, K, Gotoh, M, Hasuike, Y, Kim, T, and Murakami, T
- Abstract
We evaluated the role of magnetic resonance (MR) imaging with gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic acid (Gd-EOB-DTPA), in estimating regional liver function in a rat ischemia-reperfusion model. Ischemic liver damage was induced in the right lobe by vascular clamping for 0 (sham), 30 (I-30), 60 (I-60), and 90 min (I-90 group). The ischemic lobes in the I-60 and I-90 groups was clearly visualized as a high intensity area in the T1 images at late phase of Gd-EOB-DTPA enhancement, Moreover, the T1/2 of signal intensity in ischemic lobes significantly correlated with the duration of vascular clamping. We also observed significant correlation between T1/2 and ATP concentration in the liver tissue (r = -0.719, P = 0.04). Our results indicate that MR imaging with Gd-EOB-DTPA is useful for evaluation of regional liver function in rats. [ABSTRACT FROM AUTHOR]
- Published
- 1999
- Full Text
- View/download PDF
58. Participation of the liver in generation of a vigorous anti-donor response after inoculation of donor spleen cells
- Author
-
He, L., Gotoh, M., Dono, K., Nagano, H., Ota, H., M., ..LN.-Ohta, Y., Okuyama, Shimizu, ..LN.-J., Grochowiecki, T., Sakon, M., and Monden, M.
- Published
- 1999
- Full Text
- View/download PDF
59. Calpain- is activated in hepatocyte mitochondria during ischemia-reperfusion injury.
- Author
-
Miyoshi, H., Sakon, M., Umeshita, K., Eguchi, H., Kishimoto, S., Dono, K., Gotoh, M., Imajoh-Ohmi, S., and Monden, M.
- Published
- 1998
- Full Text
- View/download PDF
60. A protocol with FK 506 for inducing unresponsiveness to murine islet allografts
- Author
-
Fukuzaki, T., Gotoh, M., Monden, M., Dono, K., Kanai, T., and Mori, T.
- Abstract
Background.: The most favorable protocol for transplantation is inducing unresponsiveness before operation by means of nondangerous modalities. This would permit discontinuance of long-term use of immunosuppressants. In this study we developed a potential protocol for inducing unresponsiveness to islet allografts by preoperative donor spleen cell inoculation (DSI) and a single injection of FK 506. Methods.: BALB/c (H-2^d) and C57BL/6 (H-2^b) mice were used as islet donors and recipients, respectively. The streptozocin-induced diabetic mice that had been given DSI at a dose of 1 x 10^7 or 1 x 10^4 and a single injection of FK 506 (10 mg/kg intramuscularly) at different schedules (on day 1, 3, 5 or 7 relative to DSI on day 0) were subjected to islet allografting on day 10. Results.: All islet recipients returned to normoglycemia within a few days with no toxic effect of FK 506 treatment. DSI at a dose of 1 x 10^7 alone led to shortening of the mean survival time to 10.1+/-4.1 days, as compared with 13.5+/-6.3 days for the untreated animals. In contrast, marked prolongation of graft survival was induced when FK 506 was given on day 3 (>84+/-27.3 days, p<0.0001) or on day 5 after DSI (>50.9+/-46.0 days, p<0.05). Five of seven allografts given FK 506 on day 3 and three of seven allografts given FK 506 on day 5 survived indefinitely. Other time schedules of DSI and FK 506 treatment (on day 1 or 7 after DSI) or FK 506 treatment alone had no significant effect on mean survival time. With the same protocol, third-party islet allografts (C3H) were immediately rejected (10.6+/-2.6 days). Conclusions.: Prolongation of islet allograft survival was induced by certain doses of DSI and preoperative FK 506 treatment. This modality prevents an adverse effect of FK 506 on grafted islets and can induce unresponsiveness to islet allografts, offering a protocol for successful clinical islet transplantation.
- Published
- 1995
- Full Text
- View/download PDF
61. Molecular mechanism involoved in increased expression of sialyl Lewis antigens in ductal carcinoma of the pancreas
- Author
-
Nakamori, S., Shoko Nishihara, Ikehara, Y., Nagano, H., Dono, K., Sakon, M., Narimatsu, H., and Monden, M.
62. Differential-phase reflectometry using phased-array antenna system in QUEST.
- Author
-
Nagata, K., Idei, H., Sakaguchi, M., Dono, K., Wataya, Y., Kawasaki, S., Zushi, H., Hanada, K., Nakamura, K., Sakamoto, M., Hasegawa, M., Higashizono, Y., Takase, Y., Maekawa, T., Mitarai, O., Kishimoto, Y., Nakashima, H., and Higashijima, A.
- Published
- 2010
- Full Text
- View/download PDF
63. Pretreatment of Crude Pancreatic Islets With Mitomycin (MMC) Prolongs Islet Graft Survival in a Xenogeneic Rat-to-Mouse Model
- Author
-
Grochowiecki, T., Gotoh, M., Dono, K., Takeda, Y., Nishihara, M., Ohta, Y., Kimura, F., Ohzato, H., Umeshita, K., and Sakon, M.
- Published
- 1998
- Full Text
- View/download PDF
64. Microchimerism and Hyporesponsiveness Induced by Intraportal Injection of Donor Spleen Cells in Rats
- Author
-
Ota, H., Gotoh, M., Ohzato, H., Dono, K., Takeda, Y., Umeshita, K., Sakon, M., Nishisho, I., and Monden, M.
- Published
- 1997
- Full Text
- View/download PDF
65. COX-2 specific inhibitor reduces pancreatic cancer cell invasion through alteration of cellular adhesion and MMP activation
- Author
-
Okami, J., Nakamori, S., Sakon, M., Yamamoto, H., Hiraok, N., Tsujie, M., Hayashi, N., Shiozaki, K., Nagano, H., Dono, K., Umeshita, K., and Monden, M.
- Published
- 2001
- Full Text
- View/download PDF
66. Genetic lymph node staging for pancreatic cancer
- Author
-
Nakamori, S., Yamada, T., Shiozaki, K., Okami, J., Hayashi, N., Tsujie, M., Nagano, H., Dono, K., Umeshita, K., Sakon, M., and Monden, M.
- Published
- 2001
- Full Text
- View/download PDF
67. Pretreatment of islets with mitomycin C and blockage of costimulatory signal induces unresponsiveness to islet xenografts
- Author
-
Grochowiecki, T, Gotoh, M, Dono, K, Takeda, Y, Ohzato, H, Okuyama, M, Shimizu, J, Kimura, F, He, L, Nagano, H, Nakamori, S, Umeshita, K, Sakon, M, Yagita, H, Okumura, K, Miyasaka, and Monden, M
- Published
- 1999
- Full Text
- View/download PDF
68. [Questionnaire Survey on Oral Care and Oral Troubles for Patients with Gastric Cancer Received Chemotherapy].
- Author
-
Kawase T, Imamura H, Yanagimoto Y, Odagiri K, Suzuki Y, Takeyama H, Yamashita M, Sato Y, Kobayashi A, Ikenaga M, Shimizu J, Akagi K, Iwazawa T, Tomita N, and Dono K
- Subjects
- Humans, Aged, Dysgeusia etiology, Surveys and Questionnaires, Stomach Neoplasms drug therapy, Stomach Neoplasms complications, Stomatitis etiology, Xerostomia complications
- Abstract
Background: The actual situation of oral care and oral troubles for patients with gastric cancer received chemotherapy is not clear., Methods: Questionnaire survey in the form of oral questions was performed for patients with gastric cancer who received chemotherapy from December 2021 to February 2022. The relevance between the survey results and background factors was examined using the χ2 test., Results: We performed the questionnaire survey for 36 patients. Of the 36 patients, 29 patients received dental check-up before starting chemotherapy. Fourteen of the 29 patients(48%)continued the dental check-up. Of 14 patients who continued the dental check-up, 9 patients were 65 years or older, while 14 of 15 patients who discontinued the dental check-up were 65 years or older. Continuity of dental check-up was low among the elderly patients. The rate of dysgeusia were 78 vs 30% in the patients who adopted and who did not adopt oral care other than toothbrushing(p=0.01). The frequency of oral troubles was dysgeusia(47%), stomatitis(42%), and dry mouth(36%). The severity of the oral troubles was, in order, dysgeusia, dry mouth, and pain. The most common side effect due to chemotherapy causing decreased food intake was dysgeusia., Conclusions: Dysgeusia was the most frequent and severe oral trouble.
- Published
- 2024
69. [Regimen Selection by Narrative Approach in Patients with Advanced Gastric Cancer-Paclitaxel or Nab-Paclitaxel?]
- Author
-
Kawase T, Imamura H, Yanagimoto Y, Odagiri K, Suzuki Y, Takeyama H, Yamashita M, Sato Y, Kobayashi A, Ikenaga M, Shimizu J, Akagi K, Iwazawa T, Tomita N, and Dono K
- Subjects
- Male, Female, Humans, Aged, Paclitaxel, Albumins, Comorbidity, Stomach Neoplasms drug therapy
- Abstract
Background: According to the sixth Gastric Cancer Treatment Guideline, the regimen included nab-paclitaxel(nab-PTX) is a conditional recommendation as second-line treatment for advanced gastric cancer. However, the selection criteria of nab-PTX is not clear., Method: Questionnaire survey as narrative approach on the problems of paclitaxel premedication, the symptoms due to paclitaxel containing alcohol, and infusion time was conducted for patients who had been treated with paclitaxel., Results: Thirty-six patients answered the questionnaire. Nonelderly patients(<65 years)or patients without comorbid medications complained of dissatisfaction with the inconvenience due to premedication significantly more than elderly patients(≥65 years)or patients with comorbid medications. Females or nonelderly patients were significantly more troubled by sleepiness due to premedication than males or elderly patients. Eight out of 11 patients who had visited hospital by driving a car for first-line treatment were troubled by prohibition of driving on the day of treatment. Thirty out of 36 patients answered that they would feel benefits from 30-minutes shortening of infusion time., Conclusion: Questionnaire survey suggests that we may select the patients for nab-PTX properly by clarifying the inconvenience of daily life associated with premedication, the way of transportation for visiting hospital, and the benefits by shortening of infusion time.
- Published
- 2024
70. Association between methicillin-resistant Staphylococcus aureus nasal carriage and infection after pancreatic surgery.
- Author
-
Jinushi K, Shimizu J, Yamashita M, Odagiri K, Yanagimoto Y, Takeyama H, Suzuki Y, Ikenaga M, Imamura H, and Dono K
- Subjects
- Humans, Retrospective Studies, Surgical Wound Infection epidemiology, Surgical Wound Infection prevention & control, Incidence, Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections diagnosis, Staphylococcal Infections epidemiology, Staphylococcal Infections prevention & control
- Abstract
Background: Methicillin-resistant Staphylococcus aureus (MRSA) infections after pancreatectomy are relatively rare; however, they can be fatal when associated with pseudoaneurysms. For the past 12 years, we have been investigating nasal MRSA carriage by polymerase chain reaction testing, postoperatively in patients admitted to the intensive care units, to prevent nosocomial infections. Here, we investigated the relationship between MRSA nasal carriage and postoperative MRSA infection at the surgical site, following pancreatectomy., Methods: This single-center retrospective study analyzed 313 pancreatectomies (220 pancreaticoduodenectomies and 93 distal pancreatectomies), performed at our hospital between January 2011 and June 2022. The incidence of surgical site infection (SSI) and postoperative MRSA infection were compared between the nasal MRSA-positive and nasal MRSA-negative groups., Results: MRSA nasal carriage was identified in 24 cases (7.6%), and the frequency of SSIs in the nasal MRSA-positive and MRSA-negative groups were 50% and 36.7%, respectively, with no significant difference (p = .273). However, the frequency of MRSA infection among the SSI cases was significantly higher in the nasal MRSA-positive group (16.7%) than in the nasal MRSA-negative group (1.7%) (p = .003)., Conclusion: It should be noted that MRSA carriers have a significantly higher frequency of MRSA-positive SSIs., (© 2023 Japanese Society of Hepato-Biliary-Pancreatic Surgery.)
- Published
- 2024
- Full Text
- View/download PDF
71. [Clinical Outcome of Five Patients with Perforated Colorectal Cancer].
- Author
-
Jinushi K, Ikenaga M, Odagiri K, Yanagimoto Y, Yamashita M, Takeyama H, Suzuki Y, Kawase T, Shimizu J, Imamura H, and Dono K
- Subjects
- Humans, Male, Female, Endoscopy, Treatment Outcome, Retrospective Studies, Colorectal Neoplasms complications, Colorectal Neoplasms drug therapy, Colorectal Neoplasms surgery
- Abstract
We studied the clinicopathological findings of 5 patients with perforated colorectal cancer. Three patients were male, and the primary cancer site was left side colon in 4 patents. Two patients had endoscopy-related perforation. The chief complaint was abdominal pain in all cases. All patients underwent emergency surgery. Two patients had Stage Ⅱ cancer, 3 had Stage Ⅳ. The mean ICU stay was 2.8 days. The average postoperative hospital stay was 71.8 days. Three patients were discharged home and 2 were transferred to other hospitals. The 3 patients who were discharged home received chemotherapy. Perforation of the cancer site is a risk factor for recurrence, and early recovery and additional treatment should be considered.
- Published
- 2023
72. [Conversion Surgery Performed after SOX plus Nivolumab Therapy for Advanced Gastric Cancer with Para-Aortic Lymph Node Metastasis].
- Author
-
Okuda T, Odagiri K, Yanagimoto Y, Yamashita M, Takeyama H, Suzuki Y, Ikenaga M, Kawase T, Shimizu J, Imamura H, and Dono K
- Subjects
- Female, Humans, Aged, Nivolumab therapeutic use, Lymphatic Metastasis, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Neoplasm Recurrence, Local surgery, Lymph Nodes pathology, Lymph Node Excision, Gastrectomy, Stomach Neoplasms drug therapy, Stomach Neoplasms surgery, Stomach Neoplasms pathology
- Abstract
The patient was a 78-year-old woman. She presented with anemia and a positive fecal occult blood test. Endoscopic findings revealed type 3 advanced gastric cancer. As it had metastasized to the para-aortic lymph node(PALN: No. 16a2 lat), it was diagnosed as gastric cancer at cardia cT4aN1(No.1)M1(No.16a2 lat), cStage Ⅳ. She was administered S-1, oxaliplatin, and nivolumab(SOX plus Nivo)therapy as a first-line treatment. SOX plus Nivo resulted in a remarkable reduction of the lymph nodes, which were PR. After 3 courses of chemotherapy, a laparoscopic proximal gastrectomy was performed, with D2 plus No. 16a2 int/lat lymph nodes dissection as conversion surgery. Histopathological examination was pT3N0M0, and R0 resection was pStage ⅡA. She was discharged at POD21 and started S-1 from POD69. The patient is alive with no signs of recurrence 10 months postoperatively.
- Published
- 2023
73. [Our Experience with Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma].
- Author
-
Shimizu J, Yamashita M, Odagiri K, Takeyama H, Yanagimoto Y, Suzuki Y, Ikenaga M, Kawase T, Imamura H, and Dono K
- Subjects
- Female, Male, Humans, Aged, Aged, 80 and over, Bevacizumab adverse effects, Retrospective Studies, Proteinuria, Carcinoma, Hepatocellular drug therapy, Liver Neoplasms drug therapy, Hypothyroidism chemically induced, Antibodies, Monoclonal, Humanized
- Abstract
We report our experience with atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma., Methods: Fourteen patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab at our department were retrospectively evaluated for antitumor efficacy and adverse events., Results: Age ranged from 66-91 years(median 77.5 years), 11 males and 3 females, number of doses ranged from 2-26(median 13), and observation period ranged from 31-790 days (median 427 days). Antitumor efficacy was CR in 3 patients, PR in 3, SD in 6, and PD in 2. One patient with PD died 650 days after the start of treatment, but the others are still alive. Adverse events included proteinuria in 9 patients who discontinued bevacizumab, hypothyroidism requiring levothyroxine sodium hydrate in 7 patients, dermatitis in 2 patients, and colitis requiring hospitalization in 2 patients., Discussion: Despite the small number of cases, a high antitumor effect was observed with a CR rate of 21%. Although proteinuria and hypothyroidism were observed relatively frequently as adverse events, they were easily controlled and did not pose a major clinical problem.
- Published
- 2023
74. [A Case Report of SOX Therapy for an Elderly Patient with Hemorrhagic Primary Duodenal Carcinoma].
- Author
-
Kinoshita U, Kawase T, Yanagimoto Y, Odagiri K, Yamashita M, Takeyama H, Suzuki Y, Ikenaga M, Shimizu J, Imamura H, Tomita N, and Dono K
- Subjects
- Aged, 80 and over, Humans, Male, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Drug Combinations, Oxaliplatin, Carcinoma drug therapy, Duodenal Neoplasms complications, Duodenal Neoplasms drug therapy, Duodenal Neoplasms surgery, Stomach Neoplasms surgery
- Abstract
Background: Although pancreatoduodenectomy is recommended as a radical surgery for duodenal carcinoma, it has been reported that pancreatoduodenectomy in elderly patients has a high risk of surgical complications., Case Presentation: A man in his 80's was diagnosed with advanced duodenal carcinoma, presenting with anemia(Hb 5.4 g/dL). Computed tomography scanning showed wall thickening in the descending leg of the duodenum, pancreatic invasion was suspected, and clinical diagnosis was Stage ⅡB(cT4N0M0). Although radical surgery was possible, the patient refused surgery considering the risks of surgical complications. The gastroduodenal bypass surgery was performed to control bleeding, and the patient was treated with S-1 plus oxaliplatin(SOX; S-1 100 mg/body, days 1-14; oxaliplatin 100 mg/m2, day 1 q21 days). After 6 courses of the SOX regimen, the wall thickening of duodenum disappeared, and SOX was switched to S-1 monotherapy (S-1 100 mg/body, days 1-28, q42 days)according to Grade 2 thrombocytopenia and decreased performance status. After 11 courses of S-1, upper gastrointestinal endoscopy showed that the tumor had disappeared, the biopsy of duodenum showed no evidence of malignancy, and chemotherapy was terminated. The patient has been followed up for 7 months without recurrence., Conclusions: SOX for elderly patient showed efficacy against hemorrhagic duodenal carcinoma.
- Published
- 2023
75. [A Case Report of the Ascending Colon Cancer with Bullous Pemphigoid].
- Author
-
Iijima K, Ikenaga M, Takeyama H, Suzuki Y, Tomita N, Odagiri K, Yanagimoto Y, Yamashita M, Shimizu J, Kawase T, Imamura H, and Dono K
- Subjects
- Male, Humans, Aged, Colon, Ascending surgery, Colectomy, Pemphigoid, Bullous complications, Pemphigoid, Bullous drug therapy, Pemphigoid, Bullous surgery, Colonic Neoplasms complications, Colonic Neoplasms drug therapy, Colonic Neoplasms surgery, Adenocarcinoma surgery
- Abstract
The patient was a 70-year-old man. The patient had progressive anemia while taking 10 mg/day of prednisolone and 100 mg/day of mizoribine orally for bullous pemphigoid, a colonoscopy diagnosed ascending colon cancer. Adenocarcinoma, Group 5 was detected on biopsy. Abdominal computed tomography showed no metastases. The tumor was diagnosed as ascending colon cancer, cT4aN0M0, cStage Ⅱb. We performed laparoscopic right hemicolectomy and D3 dissection. Histopathological examination revealed pT3N0M0, pStage Ⅱa. In the present report, we describe a case of the ascending colon cancer with bullous pemphigoid, and discuss the case with a review of the literature.
- Published
- 2023
76. [A Case of Preoperative Chemotherapy for Advanced Gastric Cancer, Laparoscopic Total Gastrectomy, Pancreaticoduodenectomy, and Para-Aortic Lymph Node Dissection].
- Author
-
Fukuda K, Odagiri K, Yanagimoto Y, Yamashita M, Takeyama H, Suzuki Y, Ikenaga M, Kawase T, Shimizu J, Imamura H, and Dono K
- Subjects
- Humans, Lymphatic Metastasis pathology, Pancreaticoduodenectomy, Lymph Node Excision methods, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Lymph Nodes pathology, Gastrectomy methods, Stomach Neoplasms drug therapy, Stomach Neoplasms surgery, Stomach Neoplasms pathology, Laparoscopy methods
- Abstract
Bulky N+ gastric cancer has a poor prognosis. The results of JCOG0405 showed the efficacy of neoadjuvant chemotherapy with S-1 plus cisplatin combination therapy for Bulky N+ gastric cancer. JLSSG0901 demonstrated the safety and efficacy of laparoscopic surgery for advanced gastric cancer. But the safety of laparoscopic surgery for locally advanced and extensive nodal metastasis cancer(T4b, para-aortic lymph node metastasis)is not apparent. After DOS therapy, we performed total laparoscopic gastrectomy, DP(distal pancreatectomy), D2+ #16a2/b1 lat, and Roux-en-Y reconstruction, and histopathological results showed that the aortic lymph node metastasis disappeared. We controlled extensive lymph node metastasis using preoperative triplet chemotherapy. Laparoscopic surgery after preoperative chemotherapy for Bulky N+ gastric cancer can be a treatment option because we performed laparoscopic resection and para-aortic lymph node dissection with no complications, including pancreatic complications.
- Published
- 2023
77. Long-Term Feasibility of Rescue Reconstruction for Isolated Bile Ducts With Using Cystic Duct in Living Donor Liver Transplantation.
- Author
-
Kubo M, Tomimaru Y, Gotoh K, Kobayashi S, Marukawa D, Sasaki K, Iwagami Y, Yamada D, Akita H, Noda T, Takahashi H, Asaoka T, Tanemura M, Marubashi S, Nagano H, Dono K, Doki Y, and Eguchi H
- Subjects
- Humans, Living Donors, Cystic Duct surgery, Feasibility Studies, Bile Ducts surgery, Anastomosis, Surgical, Postoperative Complications, Liver Transplantation adverse effects
- Abstract
Background: The isolated bile duct is sometimes observed in the right liver graft of living donor liver transplantation (LDLT). Even though, as a rescue option, it is known to use the recipient's cystic duct (CyD) for duct-to-duct anastomosis, the long-term feasibility of rescue duct-to-CyD (D-CyD) anastomosis remains unclear., Methods: We prospectively collected data in the right liver-LDLT cohort and compared rescue D-CyD anastomosis (n = 4) with standard duct-to-hepatic duct (D-HD, n = 45) anastomosis (D-CyD group, n = 4)., Results: The observation period was over 5 years (range, 68-171 mo) after LDLT. The D-CyD group included the following anastomosis procedures: anastomosis between the intrahepatic bile duct of the graft and the CyD of the recipient and anastomosis between the posterior HD and the CyD. Surgical outcomes between the 2 groups are similar, excluding the time for the biliary reconstruction (D-CyD, 116 ± 13 min vs D-HD, 57 ± 3 min). During the period, one recipient in the D-CyD group exhibited postoperative biliary stricture and biliary stone, and 6 recipients underwent those complications in the D-HD group (D-CyD, 25.0% vs D-HD, 13.3%) All recipients in the D-CyD group are presently alive and have not experienced liver dysfunction., Conclusions: Our findings suggest that rescue D-CyD anastomosis for an isolated bile duct in a right liver LDLT is acceptable as a life-saving option in terms of long-term feasibility., Competing Interests: Declaration of Competing Interest The authors declare that they have no conflict of interest., (Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
78. The effect of specimen processing time on HER2 expression in gastric cancer and esophagogastric junction cancer: a single-center retrospective observational study.
- Author
-
Yanagimoto Y, Imamura H, Adachi S, Odagiri K, Kawase T, Yamashita M, Takeyama H, Suzuki Y, Ikenaga M, Shimizu J, Tomita N, and Dono K
- Subjects
- Humans, Body Mass Index, Esophagogastric Junction surgery, Gastrectomy, Health Facilities, Time Factors, Stomach Neoplasms genetics, Stomach Neoplasms surgery, Specimen Handling
- Abstract
Background: Recent developments in the field of companion diagnosis and molecular-targeting therapeutic agents have helped in developing treatments targeting human epidermal growth factor receptor 2 (HER2) in gastric cancer (GC) and esophagogastric junction cancer (EGJC), and the importance of accurate diagnosis of HER2 expression is increasing. However, the HER2-positivity rate significantly differs among reports in GC and EGJC, and factors that affect HER2-positivity require elucidation., Methods: The present study retrospectively examined factors related to HER2-positivity in a single institution, including age, sex, body mass index, the American Society of Anesthesiologists physical status, tumor information, and surgery information, including time to specimen processing., Results: Our study included 165 patients tested for HER2 using GC and EGJC surgery specimens among the 1,320 patients who underwent gastrectomy from January 2007 to June 2022. In total, 35 (21.2%) and 130 (78.8%) patients were HER2-positive and -negative, respectively. Multivariate analysis revealed that intestinal type (odds ratio [OR]: 3.41, 95% confidence interval [CI]: 1.44-8.09, p = 0.005), pM1 (OR: 3.99, 95% CI: 1.51-10.55, p = 0.005), and time to specimen processing of < 120 min (OR: 2.65, 95% CI: 1.01-6.98, p = 0.049) were independent factors that affected HER2-positivity., Conclusions: The outcomes of the present study indicated that intestinal type, pM, and time to specimen processing are important factors affecting HER2-positive rates in GC and EGJC. Therefore, the risk of false-negative HER2 results may be reduced by decreasing the time required to process the resected specimen. Additionally, accurate diagnosis of HER2 expression may increase the opportunity to administer molecular-targeted drugs that can expect therapeutic effects to patients appropriately., Trail Registration: Retrospectively registered., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
79. Robotic en bloc resection sparing the bladder and anus for locally advanced low rectal cancer invading the prostate-a video vignette.
- Author
-
Takeyama H, Sato M, Ikenaga M, Suzuki Y, Imamura H, and Dono K
- Subjects
- Male, Humans, Urinary Bladder surgery, Prostate, Anal Canal, Robotic Surgical Procedures, Rectal Neoplasms surgery
- Published
- 2023
- Full Text
- View/download PDF
80. Robot-assisted laparoscopic surgery with a fluorescent near-infrared ray ureteral catheter for a rectal cancer patient with pelvic kidney: A case report.
- Author
-
Hasegawa N, Takeyama H, Suzuki Y, Noura S, Ikenaga M, Odagiri K, Yanagimoto Y, Yamashita M, Shimizu J, Kawase T, Imamura H, Iwazawa T, Tomita N, and Dono K
- Subjects
- Female, Humans, Aged, 80 and over, Rectum, Infrared Rays, Urinary Catheters, Kidney, Robotic Surgical Procedures, Robotics, Laparoscopy methods, Rectal Neoplasms complications, Rectal Neoplasms surgery, Rectal Neoplasms pathology, Ureter diagnostic imaging, Ureter surgery, Situs Inversus surgery
- Abstract
An 85-year-old woman presented with a stomachache after a meal and was admitted to the previous clinic. Multi-detector computed tomography (CT) of the abdomen showed wall thickening in the rectum and right ectopic pelvic kidney. Colonoscopy revealed a mass at the rectum, and a biopsy showed adenocarcinoma. CT showed no lymphadenopathy or distant metastasis. Hartmann's procedure with fluorescent near-infrared ray ureteral catheters was used to avoid causing urinary injury. Robotic surgery was performed while checking the route of the ureter in near-infrared mode. The patient was discharged on postoperative day 14 without specific complications. This case appears to be the first of robot-assisted laparoscopic surgery for a rectal cancer patient with pelvic kidney., (© 2022 Asia Endosurgery Task Force and Japan Society of Endoscopic Surgery and John Wiley & Sons Australia, Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
81. [A Case of Peritoneal Recurrence from Ascending Colon Cancer Successfully Treated with Laparoscopic Concomitant Right Seminal Vesiculectomy in Low Anterior Resection].
- Author
-
Suzuki Y, Ikenaga M, Takeyama H, Noura S, Sato Y, Odagiri K, Yanagimoto Y, Yamashita M, Shimizu J, Kawase T, Imamura H, Akagi K, Iwazawa T, Tomita N, and Dono K
- Subjects
- Humans, Male, Colon, Ascending pathology, Fluorodeoxyglucose F18, Peritoneal Neoplasms surgery, Colonic Neoplasms surgery, Colonic Neoplasms pathology, Laparoscopy
- Abstract
A 60s male, who had laparoscopic ileocecal resection for ascending colon cancer 2 years ago, had enhanced computed tomography(CT)for follow-up and a 12-mm nodule in Douglas' pouch adjacent to right seminal vesicle and rectum was found. 18F-fluorodeoxyglucose(FDG)-positron emission tomography CT revealed abnormal accumulation of 18F-FDG only to the lesion(standardized uptake value max 2.60)and the diagnosis of peritoneal recurrence of ascending colon cancer was made. We planned and safely performed laparoscopic concomitant right seminal vesiculectomy in low anterior resection. The pathological diagnosis was peritoneal dissemination of colon cancer and the margin was pathologically negative. The postoperative course was smooth except for temporary dysuria and he was discharged on postoperative day 17. As of writing 1 year after surgery, the patient continues to do well with no sign of recurrence. Laparoscopic concomitant seminal vesiculectomy in low anterior resection can be a good option for the curative resection of peritoneal recurrence.
- Published
- 2022
82. [A Case of Effective Plasma Exchange for Thrombotic Microangiopathy during Chemotherapy for Pancreatic Cancer].
- Author
-
Yamashita M, Shimizu J, Sato Y, Odagiri K, Yanagimoto Y, Takeyama H, Suzuki Y, Ikenaga M, Kawase T, Imamura H, Akagi K, Iwasawa S, Tomita N, and Dono K
- Subjects
- Male, Humans, Aged, Plasma Exchange adverse effects, Pancreatic Neoplasms, Pancytopenia therapy, Thrombotic Microangiopathies chemically induced, Thrombotic Microangiopathies therapy, Purpura, Thrombotic Thrombocytopenic chemically induced, Purpura, Thrombotic Thrombocytopenic diagnosis, Purpura, Thrombotic Thrombocytopenic therapy, Anemia, Hemolytic etiology, Pancreatic Neoplasms drug therapy, Pancreatic Neoplasms complications
- Abstract
The patient was a 78-year-old man. After 4 courses of GEM plus nab-PTX therapy for multiple recurrent liver metastases after pancreatic body cancer surgery, the patient was aware of general malaise and edema of the extremities. Blood tests showed pancytopenia, and he was admitted to the hospital with a diagnosis of chemotherapy-induced pancytopenia. On the second day, hemolytic anemia with crushed red blood cells was observed, suggesting thrombotic microangiopathy (TMA). Considering the possibility of thrombotic thrombocytopenic purpura(TTP), the patient was started on plasma exchange with steroids. After 7 days of plasma exchange, his thrombocytopenia, hemolytic anemia, and renal dysfunction improved, and he was discharged from the hospital on the 28th day. Although GEM-induced TMA is a life-threatening complication, there is no established treatment for it. We report a case of GEM-induced TMA that was successfully treated with plasma exchange.
- Published
- 2022
83. Novel surgical method for maintaining clear vision in robot-assisted laparoscopic rectal surgery: robot smoke suction technique-A video vignette.
- Author
-
Takeyama H, Noura S, Suzuki Y, Imamura H, Tomita N, and Dono K
- Subjects
- Humans, Suction, Smoke prevention & control, Treatment Outcome, Robotics, Robotic Surgical Procedures methods, Laparoscopy methods
- Published
- 2022
- Full Text
- View/download PDF
84. Impact of aspirin discontinuation on thrombotic complications in laparoscopic colorectal cancer surgery.
- Author
-
Harino T, Noura S, Hamabe A, Ogino T, Takeyama H, Suzuki Y, Tanida T, Tomita N, and Dono K
- Subjects
- Aspirin therapeutic use, Humans, Platelet Aggregation Inhibitors therapeutic use, Postoperative Complications chemically induced, Postoperative Complications epidemiology, Postoperative Hemorrhage chemically induced, Postoperative Hemorrhage epidemiology, Retrospective Studies, Colorectal Neoplasms complications, Colorectal Neoplasms surgery, Laparoscopy adverse effects, Thrombosis epidemiology, Thrombosis etiology, Thrombosis prevention & control
- Abstract
Background: The number of patients taking antiplatelet therapy is increasing. However, there is no definitive guideline for the perioperative management of antiplatelet therapy. Conventionally, the discontinuation of antiplatelet drugs has been the basic treatment as perioperative management. Therefore, we investigated the risk of discontinuing aspirin concerning thrombotic complications in laparoscopic colorectal cancer surgery., Methods: Between January 2015 and December 2019, a total of 729 patients underwent laparoscopic colorectal cancer surgery in Toyonaka Municipal Hospital. Sixty-four patients taking antithrombotic drugs aside from aspirin were excluded from this study; the remaining 665 patients were considered eligible and divided into three groups. The patients not taking aspirin were classified as the "Control group" (n = 588). Among the patients taking aspirin, those who continued preoperative aspirin were classified as the "Aspirin group" (n = 30), and those who discontinued preoperative aspirin were classified as the "No-aspirin group" (n = 47). The Aspirin, No-aspirin, and Control groups were compared retrospectively., Result: Among the 3 groups, there were no significant difference in operative time (p = 0.14), bleeding volume (p = 0.63), or postoperative hospital stay (p = 0.06). Assessing the postoperative complication, bleeding complications were significantly more frequent in the Aspirin group (p < 0.01), although those complications were all Clavien-Dindo grade II. In contrast, thrombotic complications were significantly more frequent in the No-aspirin group (p < 0.01). Note that those complications were all Clavien-Dindo Grade III/IV. This result suggested that discontinuing aspirin increased the risk of severe thrombotic complication., Conclusion: Discontinuation of aspirin as perioperative management in laparoscopic colorectal cancer surgery increased the risk of severe thrombotic complications., (© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
85. Higher Body Mass Index Is a Simple Favorable Non-cancer Prognostic Marker for Japanese Elderly Colorectal Cancer Patients after Curative Resection.
- Author
-
Takeyama H, Noura S, Suzuki Y, Odagiri K, Yanagimoto Y, Yamashita M, Shimizu J, Kawase T, Imamura H, Iwazawa T, Tomita N, and Dono K
- Abstract
Objectives: In elderly colorectal cancer (CRC) patients, preoperative surgical indications can be controversial in some cases depending on the patient's physical condition. In comparison with younger patients, both cancer-specific survival (CSS) and non-CCS (NCSS) have an impact on the prognosis and both CSS and NCSS should be considered in the preoperative assessment. We aimed to investigate the impact of body mass index (BMI) on CSS and NCSS in Japanese elderly CRC patients., Methods: We retrospectively collected data from 471 Japanese elderly patients (≥80 years) with stage I-III CRC who underwent curative surgery from 1998 to 2017. A Kaplan-Meier survival analysis with propensity score matching (PSM) and a multivariate Cox regression analysis were performed., Results: After PSM, 123 higher BMI (≥23) and 123 lower BMI (<23) cases were matched. The higher BMI group had significantly better survival than the lower BMI group regarding NCSS and overall survival (OS; P < .001 and P < .001, respectively). The multivariate survival analysis further confirmed that the higher BMI group had significantly better survival than the lower BMI group regarding CSS, NCSS, and OS ( P = .027, P < .001, and P < .001, respectively)., Conclusions: In Japanese elderly patients with stage I-III CRC who underwent curative surgery, preoperative higher BMI was a significant and simple favorable prognostic predictor, especially for NCSS and OS., Competing Interests: Conflicts of Interest There are no conflicts of interest., (Copyright © 2022 by The Japan Society of Coloproctology.)
- Published
- 2022
- Full Text
- View/download PDF
86. Simple surgical method for clamping the rectum in robot-assisted laparoscopic rectal surgery for rectal cancer, a simple clamping technique: A video vignette.
- Author
-
Takeyama H, Noura S, Suzuki Y, Imamura H, Tomita N, and Dono K
- Subjects
- Constriction, Humans, Rectum surgery, Treatment Outcome, Laparoscopy methods, Rectal Neoplasms surgery, Robotic Surgical Procedures methods, Robotics
- Published
- 2022
- Full Text
- View/download PDF
87. [A Case of Improvement by SOX Therapy for DIC Caused by Gastric Cancer].
- Author
-
Fujimoto N, Odagiri K, Yanagimoto Y, Noguchi K, Takeyama H, Suzuki Y, Noura S, Shimizu J, Kawase T, Imamura H, and Dono K
- Subjects
- Aged, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Humans, Male, Disseminated Intravascular Coagulation drug therapy, Disseminated Intravascular Coagulation etiology, Stomach Neoplasms complications, Stomach Neoplasms drug therapy, Thrombocytopenia
- Abstract
Disseminated intravascular coagulation(DIC)has a poor prognosis in gastric cancer. The patient was a 78-year-old man. He had been diagnosed with Stage Ⅳ gastric cancer. Before chemotherapy, thrombocytopenia and elevated D-dimer occurred, and we diagnosed DIC. We started SOX therapy to treat gastric cancer with DIC. DIC improved on the 10th day after the onset of DIC. But developed DIC again on the 21st day. We started SOX therapy again. However, the DIC did not improve. The patient died 32 days after the initial DIC. Oxaliplatin regimen may be a potential treatment for DIC.
- Published
- 2021
88. Modified Cavoportal Hemitransposition for Severe Portal Vein Thrombosis Contributed to Long-term Survival After Deceased Donor Liver Transplantation-Insight Into Portal Modulation for Improving Survival: A Case Report.
- Author
-
Kubo M, Gotoh K, Kobayashi S, Iwagami Y, Yamada D, Tomimaru Y, Akita H, Noda T, Marubashi S, Nagano H, Dono K, Doki Y, and Eguchi H
- Subjects
- Humans, Liver Cirrhosis surgery, Living Donors, Male, Middle Aged, Portal Vein surgery, Liver Transplantation, Venous Thrombosis etiology, Venous Thrombosis surgery
- Abstract
Background: Severe/massive portal vein thrombosis (PVT) deteriorates peri-liver transplantation outcomes. Cavoportal hemitransposition (CPHT) is a rescue procedure for severe PVT, and short-term outcomes have been well studied. However, CPHT is associated with some long-term issues caused by portal flow modulation via extraordinary reconstruction. We describe a patient with Yerdel grade 4 PVT who underwent a liver transplant and achieved long-term survival with CPHT and a portosystemic shunt., Case Report: A 50-year-old man with liver cirrhosis underwent a deceased donor liver transplant. Preoperative examinations indicated Yerdel grade 4 PVT; thus, we planned a CPHT. In liver transplant surgery, we confirmed diffusely complete PVT and removed them as possible. After placing a liver graft, we performed CPHT and confirmed that the graft received sufficient portal vein flow. However, the gastroepiploic vein pressure increased significantly. Therefore, we added a portosystemic shunt between the splenic vein and the inferior vena cava, and the pressure improved. The patient was discharged after an uneventful hospital stay, and he reported no unfavorable events for over 12 years., Conclusions: This case study suggested that a modified CPHT with a portosystemic shunt for Grade 4 PVT was useful in preventing post-liver transplant PVT development and improved the outcome., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
89. Left paraduodenal hernia treated by single-incision laparoscopic surgery: a case report.
- Author
-
Hasegawa N, Takeyama H, Suzuki Y, Noura S, Odagiri K, Yanagimoto Y, Yamashita M, Shimizu J, Kawase T, Imamura H, Iwazawa T, Tomita N, and Dono K
- Abstract
Background: Paraduodenal hernia is a rare internal hernia which accounts for only 1% of all intestinal hernias. There have been limited reported cases of paraduodenal hernia treated by laparoscopic surgery. We report a case of left paraduodenal hernia that was successfully treated by single-incision laparoscopic surgery (SILS)., Case Presentation: A 17-year-old woman presented with left upper abdominal pain. An abdominal enhanced multi-detector computed tomography demonstrated encapsulated cluster of small bowel loops in the left upper quadrant which passed through the dorsal side of the inferior mesenteric vein, and showed that blood flow of the prolapsed small bowel was preserved. We preoperatively diagnosed left paraduodenal hernia without ischemia or necrosis. We performed elective SILS because she was a young actress training school student and cosmetic benefit was thought to be important. We pulled out the protruded small bowel and closed a defect with a running suture by SILS. The patient was discharged 3 days after the surgery with no complications., Conclusions: We reported the case of left paraduodenal hernia successfully diagnosed and treated by SILS., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
90. Clinical Utility of Bile Duct Axis Deviation for Differential Diagnosis Between Pancreatic Head Cancer and Bile Duct Cancer.
- Author
-
Shirakawa T, Tomimaru Y, Hayashi S, Noguchi K, Nishida T, and Dono K
- Subjects
- Aged, Diagnosis, Differential, Female, Humans, Male, Middle Aged, Retrospective Studies, Tomography, X-Ray Computed, Bile Duct Neoplasms diagnosis, Bile Ducts diagnostic imaging, Pancreatic Neoplasms diagnosis
- Abstract
Backgrounds: Differential diagnosis between pancreatic head cancer (PHC) and intrapancreatic bile duct cancer (BDC) is important, but no clinical standard has been established. Here we examine the diagnostic utility of bile duct axis deviation and other clinical factors for this differential diagnosis., Methods: This study enrolled patients who underwent pancreaticoduodenectomy for PHC or BDC at our center between 2009 and 2016. PHCs in groove or uncinate portions were excluded from analysis. From contrast-enhanced computed tomography images, the bile duct angle (BDA) was measured using three points: the junction of intrahepatic bile ducts, upper pancreatic edge, and Vater papilla. Logistic regression was performed to evaluate the diagnostic performance of BDA and other clinical factors for differential diagnosis., Results: During the study period, 22 PHCs and 31 BDCs were resected. The combination of BDA ≤ 130°, main pancreatic duct diameter ≥ 4.3 mm, and absence of jaundice predicted PHC rather than BDC with an area under the curve of the receiver-operator characteristics curve of .856 (95% confidence interval, .766-.947)., Conclusion: Clinical findings of larger bile duct axis deviation, main pancreatic duct dilation, and the absence of jaundice may be useful for distinguishing PHC from BDC.
- Published
- 2021
- Full Text
- View/download PDF
91. [A Case of Anastomotic Recurrent Descending Colon Cancer Successfully Treated with Single-Incision Laparoscopic Partial Colectomy with Intracorporeal Anastomosis].
- Author
-
Suzuki Y, Tanida T, Noura S, Yanagimoto Y, Noguchi K, Hirota M, Oshima K, Shimizu J, Kawase T, Imamura H, Akagi K, Iwazawa T, and Dono K
- Subjects
- Anastomosis, Surgical, Colectomy, Colon surgery, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Colon, Descending, Laparoscopy
- Abstract
A 60s-year-old male, who had laparoscopic partial colectomy with resection of left colic artery for descending colon cancer 8 years ago and completed 5-year-follow-up without the evidence of recurrence, was diagnosed as anastomotic recurrence of descending colon cancer, and referred to our hospital. We planned and safely performed single-incision laparoscopic colectomy(SILC)with intracorporeal anastomosis(ICA)(operation time of 390 min and estimated blood loss of 60 g). Following the adhesiolysis, the intracorporeal resection of the lesion was performed with automatic stapling device preserving middle colic and inferior mesenteric arteries and veins. Then, after the recovery of the specimen, ICA was performed as follows; after making a small hole just below the staple line at the opposite side of mesenteric attachment, the oral and the anal stump of colon was pulled-up and placed side-by-side with temporary strings and automatic suturing device was inserted into the holes and fired to form a side-to-side anastomosis, then the common stab incision was pulled- up with 3 temporary strings and closed with a stapler. The postoperative course was smooth and discharged on postoperative day 8. The ICA can be a good option for SILC when colonic and vascular tension would be the limiting factor of anastomosis.
- Published
- 2021
92. The Validity of a New Edition of Classification for Ovarian Metastasis from Colorectal Cancer.
- Author
-
Yoshihara T, Noura S, Tanida T, Ogino T, Noguchi K, Nagase H, Hirota M, Tomimaru Y, Imamura H, and Dono K
- Abstract
Objectives: In the 9th edition of the Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma (JCCRC), ovarian metastasis is classified as distant metastasis. We assessed the significance of resection of ovarian metastases and the validity of this 9th edition of JCCRC for ovarian metastases from colorectal cancer (CRC)., Methods: We retrospectively analyzed the clinicopathological factors and overall survival of 17 patients with ovarian metastases from CRC who underwent resection and 110 female CRC patients with Stage IV (M1a) disease., Results: The patients with only ovarian metastases who underwent resection had a longer median survival time than patients with both ovarian and peritoneal metastases who underwent resection (45.4 months vs. 9.3 months, P = 0.029). The 5-year overall survival of the patients with only ovarian metastases who underwent R0 resection was as long as that of the female Stage IV (M1a) CRC patients after R0 resection (50% vs. 48%, P = 0.334)., Conclusions: We found that, after resection, patients with only ovarian metastases had significantly better prognoses than patients with ovarian and peritoneal metastases. R0 resection of ovarian metastasis indicated as good prognosis as R0 resection of metastasis to one distant organ without ovaries. So the 9th edition of JCCRC, which classifies ovarian metastasis from CRC as distant metastasis, is appropriate., Competing Interests: Conflicts of Interest There are no conflicts of interest., (Copyright © 2021 by The Japan Society of Coloproctology.)
- Published
- 2021
- Full Text
- View/download PDF
93. [A Case of Locally Advanced Rectal Cancer with Multiple Liver Metastases Could Be Resected after Triplet Chemotherapy].
- Author
-
Tanida T, Noura S, Yanagimoto Y, Noguchi K, Hirota M, Oshima K, Shimizu J, Kawase T, Imamura H, Akagi K, Iwazawa T, and Dono K
- Subjects
- Antineoplastic Combined Chemotherapy Protocols therapeutic use, Bevacizumab therapeutic use, Humans, Male, Rectum, Liver Neoplasms drug therapy, Liver Neoplasms surgery, Rectal Neoplasms drug therapy, Rectal Neoplasms surgery
- Abstract
The patient was a 60's man, whose chief complaints were melena and weight loss. He visited our hospital, and further evaluation revealed rectal cancer(Ra)invading the abdominal wall with multiple liver metastases. The clinical diagnosis was cT4b(abdominal wall)N2bM1a(H1), cStage Ⅳ. We performed a transverse colostomy on the day prior to chemotherapy administration. He was administered 8 courses of FOLFOXIRI plus bevacizumab. After the chemotherapy, the primary tumor and liver metastases showed PR, with a diagnosis of ycT3N1bM1a(H1), Stage Ⅳ. We performed a robot-assisted laparoscopic low anterior resection for the primary tumor. Two months later, the partial resection of liver S6 and S8 was performed. The patient has been cancer-free for 6 months now.
- Published
- 2021
94. Surgical Outcome of Laparoscopic Cholecystectomy in Patients With a History of Gastrectomy.
- Author
-
Harino T, Tomimaru Y, Yokota Y, Noguchi K, Shimizu J, Taguchi T, Yanagimoto Y, Suzuki Y, Hirota M, Tanida T, Noura S, Imamura H, Iwazawa T, and Dono K
- Subjects
- Aged, Female, Gastroenterostomy, Humans, Male, Retrospective Studies, Treatment Outcome, Cholecystectomy, Laparoscopic, Gastrectomy
- Abstract
Background: Although laparoscopic cholecystectomy (LC) has been applied to patients with a history of abdominal surgery, we lack data on the surgical outcome of LC in patients with a history of gastrectomy. Here, we assessed the outcomes of LC and investigated predictive factors for conversion from laparoscopic to open surgery in patients with a gastrectomy history., Patients and Methods: We retrospectively compared the surgical outcomes of LC between patients with and without a history of gastrectomy. We performed multivariate regressions to identify independent predictive factors for open conversion during an LC., Results: Among 2235 patients who underwent LCs, 39 (1.7%) had undergone a previous gastrectomy (29 men, 10 women; mean age, 72 y; 34 with distal gastrectomy and 5 with total gastrectomy). The operation time, intraoperative bleeding, postoperative hospital stays, and conversion rate were significantly worse in patients with, compared with those without the history of gastrectomy. Conversion during an LC in the cases with a history of gastrectomy was significantly correlated with age and the type of gastrectomy., Conclusions: These results suggested that LC in patients with a history of gastrectomy exhibited worse outcomes in terms of operation time, intraoperative bleeding, postoperative hospital stay, and conversion rate than those without it. Furthermore, it was also implied that age and the type of gastrectomy were significant predictive factors for conversion during an LC in patients with a history of gastrectomy., Competing Interests: The authors declare no conflicts of interest., (Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
95. Significance of fistulography findings to the healing time of postoperative pancreatic fistula after pancreaticoduodenectomy.
- Author
-
Tomimaru Y, Tanaka K, Noguchi K, Noura SO, Imamura H, Iwazawa T, and Dono K
- Subjects
- Aged, Drainage methods, Female, Humans, Male, Middle Aged, Time Factors, Pancreatic Fistula diagnosis, Pancreatic Fistula physiopathology, Pancreaticoduodenectomy, Postoperative Complications diagnosis, Radiography methods, Wound Healing
- Abstract
Purpose: Pancreatic fistula (PF) is a common and serious complications after pancreaticoduodenectomy (PD). However, few studies have discussed the time required for PF healing in patients with this complication. This study investigates the PF healing time (PF-HT) and its association with findings of postoperative fistulography performed via the drainage tubes., Methods: The subjects of this study were 35 patients with PF among a total of 144 patients who underwent PD for periampullary diseases in our hospital. PF-HT, which was defined as the duration from the first postoperative fistulography to removal of the drainage tubes, was assessed in the enrolled patients. Fistulography findings were classified into four types based on fluid collection and communication with the jejunal loop. We investigated the factors affecting the PF-HT, including the fistulography findings., Results: The average PF-HT was 22 ± 20 days. Multivariate analysis revealed that the fistulography type was the only independent factor that affected PF-HT significantly. The PF-HT was significantly shorter in patients without fluid collection than in those with fluid collection. Moreover, those patients with fluid collection and a communication had a significantly shorter PF-HT than those without a communication., Conclusions: We found that fistulography findings were significantly associated with the PF-HT. This suggests that fistulography findings could help to predict the time needed for PF healing.
- Published
- 2020
- Full Text
- View/download PDF
96. Clinical investigation of the cystic duct variation based on the anatomy of the hepatic vasculature.
- Author
-
Fujimoto N, Tomimaru Y, Yamamoto T, Hayashi Y, Noguchi K, Noura S, Imamura H, and Dono K
- Subjects
- Humans, Anatomic Variation, Cystic Duct anatomy & histology, Liver blood supply
- Abstract
Purpose: Anatomical variation of the cystic duct (CD) is rare but can result in misunderstanding of the CD anatomy during laparoscopic cholecystectomy, potentially leading to bile duct injury. Therefore, the precise preoperative identification of CD variation is important. However, preoperative imaging analyses of the biliary system are not always possible or sufficient. We therefore investigated CD variations based on the anatomy of the hepatic vasculature., Methods: This study enrolled 480 patients who underwent imaging before hepatobiliary pancreatic surgery. We assessed the variation of the CD and hepatic vasculature and evaluated the correlations among these variations., Results: A variant CD anatomy was identified in 12 cases (2.5%) as CD draining into the right hepatic bile duct (BD) in 4 cases and into the right posterior BD in 8 cases. CD variation was significantly more common in cases with portal vein (PV) and BD variation than in those without the variation. We developed a scoring system based on the presence of PV and BD variations that showed good discriminatory power for identification of CD variants., Conclusion: Cases with a variant CD anatomy were more likely to exhibit variant PV and BD anatomies than cases with a normal CD anatomy. These findings will be useful for the preoperative identification of CD variants.
- Published
- 2020
- Full Text
- View/download PDF
97. [Long-Term Survival in a Case of Colon Cancer with Peritoneal Dissemination and Ovarian Metastasis after Multimodality Therapy].
- Author
-
Tanida T, Noura S, Ogino T, Nagase H, Noguchi K, Hirota M, Oshima K, Tomimaru Y, Kawase T, Imamura H, Akagi K, Iwazawa T, and Dono K
- Subjects
- Aged, Antineoplastic Combined Chemotherapy Protocols, Female, Humans, Neoplasm Recurrence, Local, Peritoneal Neoplasms secondary, Positron Emission Tomography Computed Tomography, Colonic Neoplasms therapy, Ovarian Neoplasms secondary, Ovarian Neoplasms therapy, Peritoneal Neoplasms therapy
- Abstract
A 70-year-old woman underwent treatment for cecal cancer(pT4bN1M0, Stage Ⅲb)in 2010. Four years and 2 months after the first surgery, she underwent ileum resection for stenosis due to perineal dissemination(P3). Two years after this recurrence, during which time she had completed 26 courses of FOLFIRI plus bevacizumab(Bmab), 9 courses of capecitabine plus oxaliplatin(CapeOX)plus Bmab, and 3 courses of Cape, no peritoneal dissemination was detected by computed tomography( CT). Thereafter, an additional 19 courses of Cape plus Bmab were introduced, but CEA continued to increase. Right ovarian metastasis was suspected based on CT and FDG-PET/CT examination. Four years and 1 month after the initial recurrence of perineal dissemination, the patient underwent bilateral ovarian resection, during which the lack of peritoneal dissemination was confirmed. Pathologically, right ovarian metastasis was diagnosed. The patient is still alive 4 years and 6 months after the first operation.
- Published
- 2020
98. Predictive Factors of Postoperative Delirium in Patients After Pancreaticoduodenectomy.
- Author
-
Tomimaru Y, Park SA, Shibata A, Miyagawa S, Noguchi K, Noura S, Imamura H, Shirakawa T, and Dono K
- Subjects
- Aged, Humans, Incidence, Pancreatectomy, Postoperative Complications epidemiology, Postoperative Complications etiology, Risk Factors, Delirium diagnosis, Delirium epidemiology, Delirium etiology, Pancreaticoduodenectomy adverse effects
- Abstract
Background: Postoperative delirium is a common serious complication after various types of surgery. However, the incidence and predictive factors associated with delirium after pancreaticoduodenectomy (PD) have not been investigated. Thus, this study aimed to investigate the incidence and predictive factors of postoperative delirium in patients who underwent PD., Methods: This study included 155 consecutive patients who underwent PD. Patients with and without postoperative delirium were compared to identify differential patient characteristics. Multivariate regression analysis was used to statistically identify independent predictive factors significantly associated with the development of postoperative delirium., Results: Postoperative delirium developed in 27 (22.4%) of 155 patients. The majority of incidents occurred on postoperative day 2, and the mean delirium duration was 4.6 ± 4.8 days. Patients with postoperative delirium had an older age and a previous history of benzodiazepine use. A multivariate analysis revealed that the development of delirium was significantly correlated with these two factors. Receiver-operator characteristics (ROC) curve analysis of the two factors yielded an area under the ROC curve of 0.823 (0.750-0.896), suggesting good discrimination power., Conclusions: This study reports on the incidence of postoperative delirium after PD. Furthermore, we identified age and use of benzodiazepines as significant predictive factors for developing delirium after PD. These results contribute to the prediction and treatment of postoperative delirium.
- Published
- 2020
- Full Text
- View/download PDF
99. [A Resected Case of Hemorrhagic Hepatic Cyst Difficult to Differentiate from Mucinous Cystic Neoplasm of the Liver].
- Author
-
Park SA, Tomimaru Y, Noguchi K, Nagase H, Ogino T, Hirota M, Oshima K, Tanida T, Noura S, Kawase T, Imamura H, Akagi K, Iwazawa T, and Dono K
- Subjects
- Aged, Female, Humans, Cysts complications, Cysts diagnosis, Diagnosis, Differential, Hemorrhage etiology, Liver Neoplasms diagnosis
- Abstract
Case: A 77-year-old woman was referred to our hospital for detailed examination of a cystic liver tumor. Contrast-enhanced CT and MRIshowed a cystic liver tumor with an enhanced mural nodule in S6 of the liver. Under a preoperative diagnosis of hemorrhagic hepatic cyst and mucinous cystic neoplasm(MCN)of the liver, extended posterior segmentectomy was performed. Histological examination of the tumor revealed no neoplastic cells, and the tumor was finally diagnosed as a hemorrhagic hepatic cyst of the liver., Conclusion: Similar to previous reports of hemorrhagic hepatic cysts, preoperative differential diagnosis from MCN of the liver was difficult in this case. Hemorrhagic hepatic cysts are rare and are sometimes confused with MCN of the liver, especially when an enhanced mural nodule is found in the cyst. The possibility of hemorrhagic hepatic cysts should be considered during diagnosis of liver cystic tumors.
- Published
- 2020
100. Analysis of anatomical variations of intrapelvic vessels for advanced pelvic surgery.
- Author
-
Hamabe A, Harino T, Ogino T, Tanida T, Noura S, Morita S, and Dono K
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Retrospective Studies, Sacrum, Iliac Artery abnormalities, Pelvis surgery
- Abstract
Background: In pelvic surgery, it is important to anticipate potential anatomic variations, which may be unknown, and inter-relationships among intrapelvic vessels. Here, we comprehensively analyzed intrapelvic vessel patterns., Method: This retrospective analysis included 81 patients that underwent colorectal surgery in our institution in 2016. A total of 162 half-pelvises were imaged with contrast-enhanced computed tomography. We scrutinized thin-slice images., Results: We found variations in the number of internal iliac veins. In 47.5% of cases, one internal iliac vein drained into the ipsilateral common iliac vein in both halves of the pelvis. In the other cases, several internal iliac veins were observed in one or both halves of the pelvis. We analyzed the inter-relationships between the superior gluteal artery and the sacral nerve plexus in pelvic halves. Superior gluteal arteries ran between the 5th lumbar nerve and 1st sacral nerves, in 82% of halves, and lateral to the 5th lumbar nerve, in 17% of halves. Dorsally, the superior gluteal artery ran on the medial side of the internal iliac vein in 15% of halves. In 28% of half-pelvises, two superior gluteal veins were observed. Superior gluteal veins passed through the sacral nerve plexus lateral to 5th lumbar, between 5th lumbar and 1st sacral, and between 1st and 2nd sacral nerve, in 42.0, 47.5, and 37.7% of halves, respectively. We evaluated the rate of symmetric pelvic anatomies, and found that all anatomic variations formed symmetrically, except the number of internal iliac veins., Conclusion: This study clarified the anatomical variations of intrapelvic vessels and their inter-relationships. These findings will benefit our understanding of pelvic anatomy and enhance the safety of radical surgery for treating pelvic diseases.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.